 vinblastin respons renal cancer high respons rate patient pulmonari metastas sixty-f patient interferon wellferon burrough wellcom Co research triangl park NC vinblastin initi six-cycl induct treatment interferon daili dose week vinblastin dose day altern cycl toxic overal respons rate signific differ treatment arm surviv differ arm small subset patient metastas lung high complet respons CR partial respons PR rate respons durabl overal surviv group patient